Back to Agenda
Transparency, Expanded Access Navigator, Right to Try: Helping Patients Get Access to Investigational Medicines?
Session Chair(s)
Kim Quaintance-Lunn
Vice President, Head of Regulatory Science and Execution, Alexion Pharmaceuticals, United States
Numerous steps have been taken to increase access to investigational medicines for patients with serious and life-threatening diseases. This session will explore whether these initiatives have had the desired impact.
Learning Objective : Describe changes to expanded access programs, including Right to Try; Assess the impact of these changes to the patient; Discuss ways to improve access to investigational medicines for patients.
Speaker(s)
Melinda Bachini
Advocacy Coordinator, Cholangiocarcinoma Foundation, United States
Patient Perspective on Preapproval Access
Beverly L Harrison
Head, Patient Support, Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Innovating Compassionate Use Request Processes with CompAC
Alison Bateman-House, PhD, MA, MPH
Assistant Professor, Division of Medical Ethics, Dept of Population Health, NYU Grossman School of Medicine, United States
Assessment of Progress
Have an account?